News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
312,402 Results
Type
Article (17502)
Company Profile (307)
Press Release (294585)
Multimedia
Podcasts (89)
Webinars (12)
Section
Business (92093)
Career Advice (302)
Deals (15000)
Drug Delivery (50)
Drug Development (52619)
Employer Resources (38)
FDA (6298)
Job Trends (6712)
News (161566)
Policy (11137)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1083)
Accelerated approval (24)
Adcomms (15)
Allergies (97)
Alliances (22892)
ALS (151)
Alzheimer's disease (1134)
Antibody-drug conjugate (ADC) (311)
Approvals (6536)
Artificial intelligence (321)
Autoimmune disease (185)
Automation (13)
Bankruptcy (112)
Best Places to Work (5317)
BIOSECURE Act (8)
Biosimilars (125)
Biotechnology (236)
Bladder cancer (123)
Brain cancer (52)
Breast cancer (407)
Cancer (3641)
Cardiovascular disease (277)
Career advice (269)
Career pathing (12)
CAR-T (241)
CDC (7)
Cell therapy (638)
Cervical cancer (21)
Clinical research (45869)
Collaboration (1326)
Company closure (2)
Compensation (679)
Complete response letters (51)
COVID-19 (1233)
CRISPR (95)
C-suite (661)
Cystic fibrosis (118)
Data (5070)
Denatured (18)
Depression (109)
Dermatology (36)
Diabetes (293)
Diagnostics (1750)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (235)
Drug pricing (69)
Drug shortages (6)
Duchenne muscular dystrophy (256)
Earnings (39963)
Editorial (33)
Employer branding (5)
Employer resources (35)
Events (55155)
Executive appointments (669)
FDA (8356)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1129)
Gene editing (201)
Generative AI (30)
Gene therapy (554)
GLP-1 (579)
Government (1389)
Grass and pollen (3)
Guidances (201)
Healthcare (7630)
HIV (26)
Huntington's disease (49)
IgA nephropathy (80)
Immunology and inflammation (220)
Immuno-oncology (64)
Indications (107)
Infectious disease (1371)
Inflammatory bowel disease (166)
Inflation Reduction Act (11)
Influenza (50)
Intellectual property (187)
Interviews (36)
IPO (8197)
IRA (23)
Job creations (1656)
Job search strategy (233)
JPM (48)
Kidney cancer (11)
Labor market (33)
Layoffs (280)
Leadership (16)
Legal (1661)
Liver cancer (46)
Longevity (20)
Lung cancer (484)
Lymphoma (283)
Machine learning (29)
Management (10)
Manufacturing (507)
MASH (143)
Medical device (3417)
Medtech (3432)
Mergers & acquisitions (7509)
Metabolic disorders (847)
mRNA (137)
Multiple sclerosis (124)
NASH (14)
Neurodegenerative disease (287)
Neuropsychiatric disorders (76)
Neuroscience (2210)
Neurotech (1)
NextGen: Class of 2026 (2449)
Non-profit (1168)
Now hiring (41)
Obesity (391)
Opinion (147)
Ovarian cancer (150)
Pain (123)
Pancreatic cancer (185)
Parkinson's disease (277)
Partnered (13)
Patents (359)
Patient recruitment (427)
Peanut (47)
People (28513)
Pharmaceutical (44)
Pharmacy benefit managers (8)
Phase 1 (16076)
Phase 2 (21185)
Phase 3 (13668)
Pipeline (4796)
Policy (129)
Postmarket research (967)
Preclinical (6686)
Press Release (33)
Prostate cancer (175)
Psychedelics (51)
Radiopharmaceuticals (264)
Rare diseases (797)
Real estate (3301)
Recruiting (13)
Regulatory (10920)
Reports (21)
Research institute (1088)
Resumes & cover letters (47)
Rett syndrome (29)
RNA editing (22)
RSV (24)
Schizophrenia (136)
Series A (215)
Series B (150)
Service/supplier (1)
Sickle cell disease (85)
Special edition (20)
Spinal muscular atrophy (126)
Sponsored (17)
Startups (2130)
State (2)
Stomach cancer (7)
Supply chain (45)
Tariffs (27)
The Weekly (69)
Vaccines (409)
Venture capital (81)
Weight loss (211)
Women's health (38)
Worklife (3)
Date
Last 7 days (409)
Last 30 days (1553)
Last 365 days (18659)
2026 (4803)
2025 (18982)
2024 (21517)
2023 (23646)
2022 (28279)
2021 (29411)
2020 (25206)
2019 (18722)
2018 (13732)
2017 (15271)
2016 (13229)
2015 (16131)
2014 (11725)
2013 (8491)
2012 (8614)
2011 (8783)
2010 (8385)
Location
Africa (212)
Alabama (73)
Alaska (2)
Arizona (88)
Arkansas (6)
Asia (20038)
Australia (3313)
California (8001)
Canada (2091)
China (907)
Colorado (293)
Connecticut (292)
Delaware (279)
Europe (42752)
Florida (1049)
Georgia (243)
Hawaii (2)
Idaho (22)
Illinois (483)
India (40)
Indiana (200)
Iowa (9)
Japan (295)
Kansas (84)
Kentucky (13)
Louisiana (16)
Maine (18)
Maryland (837)
Massachusetts (6304)
Michigan (137)
Minnesota (294)
Mississippi (3)
Missouri (41)
Montana (19)
Nebraska (7)
Nevada (47)
New Hampshire (30)
New Jersey (1955)
New Mexico (15)
New York (2015)
North Carolina (942)
North Dakota (6)
Northern California (3973)
Ohio (208)
Oklahoma (11)
Oregon (26)
Pennsylvania (1499)
Puerto Rico (10)
Rhode Island (30)
South America (303)
South Carolina (12)
Southern California (3209)
Tennessee (65)
Texas (1075)
United States (26787)
Utah (127)
Virginia (166)
Washington D.C. (40)
Washington State (668)
West Virginia (3)
Wisconsin (56)
312,402 Results for "nine square therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
JPM26: Filling C-Suites, Union Square—and Elevators—With Pink
Attendance at the Biotech CEO Sisterhood’s annual photo of women leaders and allies in Union Square doubled this year. There’s still more work to do.
January 21, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
January 28, 2026
·
5 min read
Press Releases
Coeptis Receives Shareholder Approval Towards Z Squared Merger
February 6, 2026
·
5 min read
Press Releases
Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared
January 6, 2026
·
5 min read
Press Releases
SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic
February 26, 2026
·
5 min read
Press Releases
Genmab Announces Financial Results for the Nine Months of 2025
November 7, 2025
·
7 min read
Press Releases
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2025
October 21, 2025
·
19 min read
Press Releases
SpectronRx Secures $85 Million to Expand Medical Isotope Production, CDMO and CMO Capabilities at Grissom Aeroplex Campus
34-acre campus supports 200,000 square feet of GMP manufacturing, with long-term expansion capacity exceeding one million square feet
April 2, 2026
·
1 min read
Press Releases
RenovoRx Expands RenovoCath® Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center
January 20, 2026
·
11 min read
Biotech Bay
Nine Square Therapeutics Awarded $4.5 Million Grant from The Michael J. Fox Foundation to Advance Development of Novel Parkin Activators
Nine Square Therapeutics announced that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research.
September 12, 2023
·
3 min read
1 of 31,241
Next
